These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A prospective randomized comparative study of targeted versus empirical prophylactic antibiotics in the prevention of infective complications following transrectal ultrasound-guided prostate biopsy. Doherty AF; Ikuerowo SO; Jeje EA; Ibrahim NA; Ojongbede OL; Mutiu WB; Omisanjo OA; Abolarinwa AA Ann Afr Med; 2019; 18(3):132-137. PubMed ID: 31417013 [TBL] [Abstract][Full Text] [Related]
5. Prevalence and significance of fluoroquinolone-resistant bacteria carriage in patients undergoing transrectal ultrasound prostate biopsy. Hasanzadeh A; Pourmand MR; Alizadeh A; Pourmand G Urol J; 2017 May; 14(3):3085-3090. PubMed ID: 28537050 [TBL] [Abstract][Full Text] [Related]
6. Comparative Effectiveness of Targeted vs Empirical Antibiotic Prophylaxis to Prevent Sepsis from Transrectal Prostate Biopsy: A Retrospective Analysis. Liss MA; Kim W; Moskowitz D; Szabo RJ J Urol; 2015 Aug; 194(2):397-402. PubMed ID: 25846415 [TBL] [Abstract][Full Text] [Related]
7. Molecular genetic testing does not improve the detection of fluoroquinolone resistance before transrectal prostate biopsy. Liss MA; Garg H; Sokurenko EV; Patterson JE; Wickes BL Prostate Int; 2022 Dec; 10(4):194-199. PubMed ID: 36570643 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of fluoroquinolone-resistant rectal flora in patients undergoing transrectal ultrasound-guided prostate needle biopsy: A prospective multicenter study. Chung HS; Hwang EC; Yu HS; Jung SI; Lee SJ; Lim DH; Cho WJ; Choe HS; Lee SJ; Park SW Int J Urol; 2018 Mar; 25(3):278-283. PubMed ID: 29241300 [TBL] [Abstract][Full Text] [Related]
9. Targeted antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy during active surveillance: Effect on hospitalization. Cheung C; Patel HD; Landis P; Carter HB; Han M Urol Oncol; 2018 Apr; 36(4):158.e7-158.e12. PubMed ID: 29288004 [TBL] [Abstract][Full Text] [Related]
10. Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy. Taylor S; Margolick J; Abughosh Z; Goldenberg SL; Lange D; Bowie WR; Bell R; Roscoe D; Machan L; Black P BJU Int; 2013 May; 111(6):946-53. PubMed ID: 23464844 [TBL] [Abstract][Full Text] [Related]
11. Prevalence and characteristics of fecal antimicrobial-resistant Escherichia coli in a cohort of Japanese men undergoing prostate biopsy. Kamei J; Yagihara Y; Kume H; Horiuchi T; Sato T; Nakagawa T; Fujimura T; Fukuhara H; Moriya K; Homma Y Int J Urol; 2017 Apr; 24(4):295-300. PubMed ID: 28222483 [TBL] [Abstract][Full Text] [Related]
15. Use of fosfomycin as targeted antibiotic prophylaxis before prostate biopsy: A prospective randomized study. Van Besien J; Uvin P; Weyne E; Van Praet C; Merckx L; De Graeve N; Van Renterghem K; Cartuyvels R; Van den Abeele AM Int J Urol; 2019 Mar; 26(3):391-397. PubMed ID: 30588680 [TBL] [Abstract][Full Text] [Related]
16. Impact of selective media for detecting fluoroquinolone-insusceptible/extended-spectrum beta-lactamase-producing Escherichia coli before transrectal prostate biopsy. Sadahira T; Wada K; Araki M; Ishii A; Watanabe T; Nasu Y; Tsugawa M; Takenaka T; Nasu Y; Kumon H Int J Urol; 2017 Dec; 24(12):842-847. PubMed ID: 28929546 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of ciprofloxacin-resistant Enterobacteriaceae in the intestinal flora of patients undergoing transrectal prostate biopsy in Norwich, UK. Hanna MY; Tremlett C; Josan G; Eltom A; Mills R; Rochester M; Livermore DM BJU Int; 2015 Jul; 116(1):131-4. PubMed ID: 25079680 [TBL] [Abstract][Full Text] [Related]